Veriskin logo — Medical is a device company that developing new technologies...

Veriskin

Medical is a device company that developing new technologies for skin cancer diagnostics.

Founded 2004 2 employees Seed Total: $3.00M Biotechnology

General Information

Company Name Veriskin
Founded Year 2004
Employees 2
Industries Biotechnology
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Veriskin. To contact Veriskin, visit veriskin.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Veriskin compare?

A PDF of Veriskin and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Veriskin soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Veriskin

Veriskin is a biotechnology startup founded in 2004 that specializes in developing new technologies for skin cancer diagnostics. The company recently secured a $1.00M Seed Round investment on 19 March 2021, with funding coming from prominent investors including Pasadena Angels, Frontier Angel Fund, TiE SoCal Angels, and Ariel Savannah Angel Partners. Veriskin's innovative approach to medical devices is directed towards revolutionizing skin cancer diagnostics, thereby presenting a compelling opportunity for venture capital firms seeking to invest in the rapidly evolving biotechnology sector. With its slogan "Medical is a device company that's developing new technologies for skin cancer diagnostics," Veriskin aims to drive significant advancements in the diagnosis and treatment of skin cancer, making it a promising prospect for potential investors.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $1.00M 4
Pasadena Angels, TiE SoCal Angels +2
19 Mar 2021
Seed Round Undisclosed -
26 Oct 2020
Grant $2.00M 1
National Cancer Institute
01 Mar 2020

Veriskin Alternatives & Competitors

View All Alternatives
Veriskin vs

Company specialized in developing new and advanced materials solutions for skin-interacting medical...

Non Equity Assistance
9 employees
Biotechnology, Health Care
Veriskin vs

Dilon Technologies is a medical device company that focuses on products that assist in the fight aga...

Debt Financing
74 employees
Biotechnology, Health Care
Veriskin vs
Perfuze
Perfuze Ireland

Neurovascular medical device company developing technology for Ischemic Stroke

Series A
33 employees
Biotechnology, Health Care

FAQ About Veriskin

Medical is a device company that developing new technologies for skin cancer diagnostics.
Veriskin was founded in 2004.
Veriskin operates in Biotechnology.
Veriskin has approximately 2 employees.
Veriskin has completed 3 funding rounds, raising a total of $3.00M. The latest funding stage is Seed.
Top alternatives and competitors to Veriskin include BestHealth4U, Dilon Technologies Inc., Perfuze, Humed Technologies, Inc., MetaGuideX Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Veriskin and BestHealth4U are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Veriskin, https://bouncewatch.com/company/veriskin, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes